Lv4
680 积分 2024-10-29 加入
Inflammation and hypoxia linked to renal injury by CCAAT/enhancer-binding protein δ
1个月前
已完结
Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous Nephropathy
1个月前
已完结
Urinary rituximab loss and rate of treatment failure in membranous nephropathy
1个月前
已完结
Update on the Application of Monoclonal Antibody Therapy in Primary Membranous Nephropathy
1个月前
已完结
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial
1个月前
已完结
Membranous Nephropathy: Updates on Management
1个月前
已完结
Exploring PLA2R and HLA in membranous nephropathy: A narrative review of pathogenic mechanisms and emerging therapeutic potentials
1个月前
已完结
Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy
2个月前
已完结
Pathological characteristics of light chain crystalline podocytopathy
2个月前
已完结
皖公网安备34019202002308
